Navigation Links
Consumers Desperate For Measures To Curb Prescription Drug Abuse
Date:8/21/2014

CINCINNATI, Aug. 21, 2014 /PRNewswire/ -- Seventy-one percent of Americans believe the abuse of strong prescription pain medications such as OxyContin is a serious public health and safety issue in the United States, according to findings from a survey released today by Repass & Partners, a Cincinnati based research firm.  

"Americans understand the severity of the prescription medication abuse problem and the need for medical innovation to make progress with this very serious health situation facing our country," Rex Repass, CEO of the survey research firm said.  "More than nine in ten respondents said that developing new technologies to prevent drug abuse is an important key to reducing the abuse crisis and improving health safety in the U.S."  Repass added that two-thirds of Americans also believe prescription opioid based pain medications are abused more often than illegal drugs such as heroin. 

Focusing on more community rehabilitation, stricter regulation of prescribing doctors, and increased law enforcement are not enough to curb the problem, the survey finds.  Nine out of ten (92%) respondents said new techniques to make medications more difficult to abuse are an important step in abuse prevention.  In addition, almost three-quarters of Americans said they would even pay higher costs for these abuse deterrent drugs, according to the survey findings.

Research from the Centers for Disease Control and Prevention (CDC) has found that drug overdoses in the United States have more than tripled since 1990. Many of these deaths are the result of overdoses of prescription pain and ADHD medications, according to CDC data. 

A common means of abusing these medications is to crush the pills and then inhale or inject the ingredients to get a quick high.  New abuse deterrent technologies (ADFs) are being developed to make it more difficult to tamper with or otherwise abuse prescription opioids. Examples of ADFs include gelling, hardness, bittering agents, anti-crush mechanisms and extended release. 

Recently, two powerful painkillers have been approved by the FDA.  Targiniq ER was approved with an ADF that blocks the drug's effect when crushed, and Zohydro, which is ten times stronger than Vicodin, was approved without an abuse deterrence of any kind. Medical groups, law enforcement agencies and state leaders have expressed serious concern over the potential for abuse of Zohydro. 

While OxyContin introduced an abuse deterrent version of its product in 2010 and we have seen the abuse of this prescription drug dramatically decline, there is currently no mandatory requirement to include abuse deterrents in painkillers or attention-deficit disorder medications.

"What also struck me was that most respondents – seventy-five percent – believe that prescription costs are too high, yet almost the same percentage are willing to pay more for abuse deterrent drugs," Repass said.  "That is another indication of how serious the abuse problem has become."

The survey was conducted from August 6 – 13 and included 1,501 respondents who answered questions through an online consumer panel.

About Repass & Partners, Inc.

Repass & Partners, Inc. is a custom survey research and strategic consulting firm based in Cincinnati.  The firm's services range from consulting with clients to identify research objectives, through study design, data collection, analysis, and research-based strategy recommendations.  The company is headquartered in Cincinnati, Ohio with a client service office in Washington, DC and a field/data collection center in Charleston, W.Va.  This study was conducted using the MindField Online™ monthly omnibus survey of 1,500 adult Americans, balanced to census demographics and geographic regions of the United States.  Repass & Partners is a member of the Counsel of American Survey Research Organizations (CASRO). 


'/>"/>
SOURCE Repass & Partners
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Incentivated Helps Scottish Government Service Consumers by SMS
2. Study Assesses New Tools, Technologies, and Approaches for Understanding and Communicating with Consumers
3. Consumer Marketing Research Innovation: Assessing New Tools for Understanding and Communicating with Consumers
4. Consumers Union Calls On Medical Device Makers to Provide Warranties for Hip & Knee Implants
5. Deceptive Practices By Illegal Online Drug Sellers Give Consumers a False Sense of Legitimacy and Safety, Reports NABP
6. New Medication Management And Adherence App, MyMeds, Introduced For iPhone, Android, Web; Unites Consumers, Pharmacists, Caregivers, Physicians
7. Supreme Court Ruling on Rx Industrys Pay-to-Delay-Generics Good News for NY Consumers
8. Consumers Union Urges FDA To Require Safety Testing of Metal on Metal Hips and Other High Risk Implants
9. Healthrageous Unveils Accountable Health The Missing Piece To Engage Consumers In Their Health And Achieve Accountable Care Goals
10. PCMA: New Report Shows Anti-PBM Laws Could Raise Health Care Costs for Oklahoma Businesses, Consumers, Government Programs
11. FastMed Urgent Care and MedVantx Offer Consumers First Ever Access to Free Samples of Medications through an Automated Medication Cabinet Across North Carolinas Largest Network of Urgent Care Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Menopause Drugs Price Analysis and Strategies - 2016, provides drug ... answers the following questions: What are the ... positioned in the Global Menopause market? What are the ...
Breaking Medicine Technology:
(Date:2/23/2017)... Boston, MA (PRWEB) , ... February 23, 2017 ... ... Education and Department of Justice jointly issued a letter to withdraw ... in accordance with their gender identity. The guidance issued in May 2016 by ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association ... Annual Meeting. KLS is a longtime supporter of the event. , "We are ... Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a global data and ... Premier Research, a leading clinical development service provider, has selected ERT’s Trial Oversight ... due in part to an array of circumstances including the use of multiple ...
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
Breaking Medicine News(10 mins):